Free Access
Issue |
J Extra Corpor Technol
Volume 41, Number 2, June 2009
|
|
---|---|---|
Page(s) | 97 - 104 | |
DOI | https://doi.org/10.1051/ject/200941097 | |
Published online | 15 June 2009 |
- Despotis GJ, Avidan MS, Hogue CWJr. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg. 2001;72:S1821–31. [CrossRef] [Google Scholar]
- Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: A review. Intensive Care Med. 2004;30:1873–81. [CrossRef] [PubMed] [Google Scholar]
- Greilich PE, Brouse CF, Rinder CS, et al. Effects of epsilonaminocaproic acid and aprotinin on leukocyte-platelet adhesion in patients undergoing cardiac surgery. Anesthesiology. 2004;100:225–3. [CrossRef] [PubMed] [Google Scholar]
- Kondo C, Tanaka K, Takagi K, et al. Platelet dysfunction during cardiopulmonary bypass surgery. With special reference to platelet membrane glycoproteins. ASAIO J. 1993;39:M550–3. [Google Scholar]
- Metzelaar MJ, Korteweg J, Sixma JJ, Nieuwenhuis HK. Comparison of platelet membrane markers for the detection of platelet activation in vitro and during platelet storage and cardiopulmonary bypass surgery. J Lab Clin Med. 1993;121:579–87. [Google Scholar]
- Siddiqui MA, Scott LJ. Recombinant factor VIIa (Eptacog Alfa): A review of its use in congenital or acquired haemophilia and other congenital bleeding disorders. Drugs. 2005;65:1161–77. [CrossRef] [PubMed] [Google Scholar]
- Monroe D, Hoffman M, Oliver J, Roberts H. Platelet activity of high-dose factor VIIa in independent of tissue factor. Br J Haematol. 1997;99:542–7. [CrossRef] [Google Scholar]
- Hoffman M, Monroe D. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis. Semin Hematol. 2001;38(Suppl 12):6–9. [CrossRef] [Google Scholar]
- Friederich PW, Henny CP, Messelink EJ, et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy:A double-blind placebo-controlled randomised trial. Lancet. 2003;361:201–5. [CrossRef] [PubMed] [Google Scholar]
- Boffard KD, Riou B, Warren B, et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma. 2005;59:8–15. [CrossRef] [PubMed] [Google Scholar]
- Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777–85. [CrossRef] [PubMed] [Google Scholar]
- Weiskopf RB. The use of recombinant activated coagulation factor VII for spine surgery. Eur Spine J. 2004;13(Suppl 1):S83–8. [CrossRef] [PubMed] [Google Scholar]
- Karkouti K, Beattie WS, Wijeysundera DN, et al. Recombinant factor VIIa for intractable blood loss after cardiac surgery: A propensity score-matched case-control analysis. Transfusion. 2005;45:26–34. [CrossRef] [PubMed] [Google Scholar]
- Pychynska-Pokorska M, Moll JJ, Krajewski W, Jarosik P. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. Pediatr Crit Care Med. 2004;5:246–50. [CrossRef] [PubMed] [Google Scholar]
- Razon Y, Erez E, Vidne B, et al. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease. Paediatr Anaesth. 2005;15:235–40. [CrossRef] [PubMed] [Google Scholar]
- Diprose P, Herbertson MJ, O’Shaughnessy D, Gill RS. Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: Randomized double-blind placebo-controlled pilot study. Br J Anaesth. 2005;95:596–602. [CrossRef] [Google Scholar]
- Kjalke M, Kjellev S, Rojkjaer R. Preferential localization of recombinant FVIIa to platelets activated with a combination of thrombin and collagen GPVI receptor agonist. J Thromb Haemost. 2007;5:774–80. [CrossRef] [Google Scholar]
- Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL. Surface expression and functional characterization of alpha-granule factor V in human platelets: Effects of ionophore A23187, thrombin, collagen, and convulxin. Blood. 2000;95:1694–702. [CrossRef] [PubMed] [Google Scholar]
- Kempton CL, Hoffman M, Roberts HR, Monroe DM. Platelet heterogeneity: Variation in coagulation complexes on platelet subpopulations. Arterioscler Thromb Vasc Biol. 2005;25:861–6. [CrossRef] [PubMed] [Google Scholar]
- Dale GL. Coated-platelets: An emerging component of the procoagulant response. J Thromb Haemost. 2005;3:2185–92. [CrossRef] [Google Scholar]
- Alberio LJ, Clemetson KJ. All platelets are not equal: COAT platelets. Curr Hematol Rep. 2004;3:338–43. [Google Scholar]
- Kestin AS, Valeri CR, Khuri SF, et al. The platelet function defect of cardiopulmonary bypass. Blood. 1993;82:107–17. [CrossRef] [PubMed] [Google Scholar]
- Holada K, Simak J, Kucera V, Roznova L, Eckschlager T. Platelet membrane receptors during short cardiopulmonary bypass: A flow cytometric study. Perfusion. 1996;11:401–6. [CrossRef] [PubMed] [Google Scholar]
- Leytin V, Allen DA, Mykhaylov S, et al. Pathologic high shear stress induces apoptosis events in human platelets. Biochem Biophys Res Commun. 2004;320:303–10. [CrossRef] [Google Scholar]
- Dale GL, Remenyi G, Friese P. Quantitation of microparticles released from coated-platelets. J Thromb Haemost. 2005;3:2081–8. [CrossRef] [Google Scholar]
- O’Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA. 2006;295:293–8. [CrossRef] [PubMed] [Google Scholar]
- Weerasinghe A, Taylor KM. The platelet in cardiopulmonary bypass. Ann Thorac Surg. 1998;66:2145–52. [CrossRef] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.